融信中國(03301.HK)曾回吐6.5% 核數師辭任延遲公布全年業績
內房股融信中國(03301.HK)核數師辭任延遲公布全年業績。該股三連彈後,今早重失20天線(2.42元),曾回吐6.5%低見2.29元,現報2.35元,回吐4.1%,成交184萬股。
融信中國公布,羅兵咸永道已於上周五(18日)起正式辭任公司核數師,其在辭任函中表明,管理層要澄清個別銀行存款抵押情況,而且相關確認函的收發工作也落後於計劃,雙方在審核費用協商也未能夠達成共識,故辭任融信核數師。
此外,內地近期爆發新冠疫情,集團的財務匯報及審核程序受到不利影響,故公司無法於3月底前刊發去年度業績。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.